Coronary scoring balloon is a temporary angioplasty balloon used to prepare a coronary stenosis before a stent or a drug-coated balloon. Surface elements aim to concentrate inflation force along defined lines. It is removed afterwards and is not left in the artery. It does not deliver a drug, scrape or clear calcium, and is not required in every coronary procedure.[4,5]
What does a scoring balloon mean?
Scoring means a controlled linear surface effect; it does not mean cutting the artery, removing calcium or guaranteeing stent expansion. The aim is to transmit balloon force more focally to help prepare the lumen. That does not mean an adequate result or fewer complications in every lesion.[4,5]
Construction, crossing profile and inflation behaviour are product-specific, so this page does not publish a universal pressure, diameter, duration or device sequence. A scoring balloon is not a permanent implant; it is inflated, the result is checked and it is removed with the catheter.[4,9]
How does it differ from other balloons and methods?
More than one tool may be used in the same procedure. That does not make the categories interchangeable or give them the same evidence.
| Feature | Scoring balloon | Cutting balloon | Standard NC balloon | Super high-pressure NC (e.g. OPN NC) | Drug-coated balloon (DCB) |
|---|---|---|---|---|---|
| Main purpose | Focused preparation via surface elements | Linear plaque modification with microblades | Controlled mechanical expansion | Selected resistant lesions not opened by a standard NC balloon | Drug transfer to the vessel wall |
| Remains in the artery? | No | No | No | No | No |
| Removes calcium? | No | No | No | No | No |
| Delivers drug? | No | No | No | No | Yes |
| Needed in every patient? | No; by lesion and result | No | No | No; a separate device class | No |
Cutting and scoring balloons may share the “modified balloon” heading; their clinical results must not be pooled. A cutting-balloon subgroup signal must not be transferred to scoring devices.[5,6]
Intravascular lithotripsy (IVL) uses acoustic shockwaves and rotational atherectomy uses debulking/ablation. A scoring balloon is not a universal substitute. Peripheral balloons are outside this coronary evidence.[4,5]

How do scoring-balloon designs differ?
“Scoring balloon” is not a single product. The element that concentrates force differs by device. One product’s result is not evidence for the others.[2–4]
Scoreflex and Scoreflex NC
Scoreflex is a semi-compliant dual-wire focused-force design. “Wired balloon” may be an informal description of certain wire-based devices; it is not the category name for all scoring balloons.[2]
Scoreflex NC is a focused-force catheter in which an NC balloon, an integral outer wire and the guidewire act as scoring elements. A 200-patient single-arm registry reports procedural success; it is not comparative efficacy evidence.[9]
AngioSculpt
AngioSculpt uses helical nitinol elements around the balloon. It was the most common device in the mixed modified-balloon arm of PREPARE-CALC; that arm also included a cutting balloon and is not a pure scoring trial.[4,7]
NSE Alpha
NSE Alpha is a semi-compliant balloon with three triangular nylon scoring elements on the outer surface. ISAR-CALC compared this device with OPN NC after standard-NC failure; the result cannot be transported to other scoring designs.[3]
Wedge NC and Naviscore
Wedge NC is a novel scoring catheter compared with Scoreflex in a 2025 multicentre open-label non-inferiority trial. Exact construction was not verified in the retrieved record. The result is a procedure-success comparison between Wedge NC and Scoreflex, not evidence that all scoring balloons are interchangeable.[1]
Naviscore is an 85-patient first-in-man registry in moderate-to-severe de novo calcified lesions. Construction and identifiers were not verified in this package; an uncontrolled registry is not comparative superiority.[10]

When may it be considered?
A scoring balloon is not a routine step before every stent or in every calcified stenosis. Use depends on whether the lesion can be crossed, calcium morphology, the stent or drug-coated balloon plan and, when used, intravascular imaging.[4,5]
Calcified de novo stenoses
In a new (de novo) calcified stenosis a scoring balloon may be one preparation option before stenting. Small randomised comparisons examine angiographic or OCT metrics and do not show class-wide clinical superiority. Uncrossable lesions or those not opened by a standard NC balloon may need other tools.[2,3,7]
DES in-stent restenosis and drug-coated balloon preparation
In drug-eluting stent in-stent restenosis (DES-ISR), a scoring balloon has been studied as neointimal preparation before a drug-coated balloon (DCB). That evidence must not be folded into de novo calcified-lesion evidence. The scoring balloon itself does not transfer drug; whether it helps the angiographic effect of DCB is a separate question and does not show fewer deaths or infarctions.[8]

When may it be insufficient alone?
A scoring balloon may not be enough in deep or circumferential calcium, uncrossable lesions, under-expanded stents or when another mechanism dominates. Consensus texts note that other methods may be needed according to calcium phenotype; a single balloon is not a guaranteed solution.[4,5]
A different strategy may be needed when:
- The balloon cannot cross the stenosis
- The balloon crosses but cannot expand the lesion adequately
- Standard NC or scoring preparation remains inadequate
- Deep, long or circumferential calcium needs another modification method
- Calcium beneath a stent resists balloon force
- Dissection or flow-limiting vessel injury occurs during the procedure
A cutting balloon, a standard or super high-pressure NC balloon, rotational atherectomy, IVL or a combined approach may then be considered. These tools are not universal substitutes for one another.[4,5,7]

Why may IVUS or OCT be used?
Coronary angiography gives a two-dimensional lumen view and can miss calcium depth, circumferential extent and true stent expansion. Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) provide cross-sectional images that can help assess whether calcium is superficial or deep, whether a balloon or stent has expanded, whether the stent is apposed, and the mechanism of restenosis.[4,5]
SCAI and EAPCI consensus documents separate cutting and scoring designs and discuss intravascular imaging as a guide to calcium phenotype. That does not mean imaging prevents heart attack or death, or that it is technically possible in every patient. No universal expansion cut-off is published here.[4,5]

How is the procedure performed?
The procedure is done in a catheter laboratory equipped for coronary angiography and PCI. It is not a separate operation unique to the scoring balloon; the patient experience is similar to other coronary balloon-stent procedures:[15]
- Preparation: History, medicines, blood tests, kidney function and contrast risk are reviewed.
- Access: Radial or femoral artery under local anaesthesia.
- Imaging and wire: The artery is imaged; a fine wire is advanced beyond the stenosis.
- Preparation and treatment plan: The team chooses a scoring balloon, NC balloon, stent, drug-coated balloon or another tool according to the lesion and the live result.
- Result check: Flow, residual stenosis and, when used, IVUS/OCT findings are reassessed.
- Removal: The scoring balloon is removed. If a stent was placed, the lasting structure is the stent.
Most patients remain awake. Brief chest discomfort during inflation should be reported if new or severe.[15]
This page does not prescribe pressure, inflation time, balloon diameter or device order.
What does the scientific evidence show?
De novo and calcified lesions
Sadamatsu and colleagues compared a Scoreflex dual-wire balloon with a standard NC balloon in 46 elective de novo lesions. Acute stent expansion did not differ; angiographic late loss was lower in the scoring arm among the angiographic follow-up subset, while MACE did not differ significantly. The study was single-centre, used first-generation drug-eluting stents, excluded difficult severe calcification and was not powered for clinical outcomes.[2]
ISAR-CALC compared NSE Alpha with OPN NC after unsuccessful standard-NC preparation in severely calcified lesions (74 patients). OCT stent-expansion index was similar (0.68 scoring vs 0.72 OPN NC). Final lumen diameter was larger and residual stenosis lower with OPN NC. Each arm had three assigned-device crossing failures requiring rotational atherectomy; two acute-stent-thrombosis myocardial infarctions occurred in the scoring arm. The trial is small and not transportable to other balloon designs.[3]
PREPARE-CALC compared rotational atherectomy with a mixed modified-balloon strategy in severely calcified native lesions (200 patients). The modified arm used AngioSculpt 83.8%, Scoreflex 12.9% and a Flextome cutting balloon 3.3%. Strategy success was 81% versus 98% with rotational atherectomy; failures were chiefly uncrossable or undilatable lesions needing bailout atherectomy. At nine months late loss was non-inferior and clinical events were low. The study cannot show scoring-specific or patient-important superiority.[7]
The Wedge NC trial randomised 198 patients to Wedge NC or Scoreflex. Procedure success was 98/99 in each arm and non-inferiority was met. Immediate lumen diameter and acute gain were somewhat higher with Wedge. Accessible evidence describes comparably low complications; arm-level counts were not verified and are not given here. This is a short-horizon comparison between two scoring devices.[1]
The Naviscore registry reported 76% first-device crossing and 94% procedural success in 85 moderate-to-severe de novo calcified lesions, with no in-hospital MACE, perforation, entrapment or flow-limiting dissection. Type A/B dissections were 13%. There is no randomised comparator; a superiority claim cannot be made.[10]
DES-ISR and DCB preparation
ISAR-DESIRE 4 compared scoring predilation before DCB with standard DCB therapy in 252 patients with DES-ISR. Follow-up in-segment stenosis was 35.0% versus 40.4% and binary restenosis 18.5% versus 32.0%. Death/MI (4.0% vs 3.4%) and target-lesion revascularisation (16.2% vs 21.8%) did not differ significantly; no target-lesion thrombosis was reported by one year. This is an angiographic DCB-preparation result, not proof of mortality/MI benefit or that the scoring balloon transfers drug, and not de novo calcium evidence.[8]
Pooled analyses and evidence limits
Scalamogna 2023 pooled six randomised trials (648 participants) under a combined cutting/scoring modified-balloon heading. There was no statistically reliable overall difference for MACE, individual clinical outcomes or final imaging minimum stent area. An exploratory interaction favoured cutting balloons, while scoring-balloon benefit was not observed. A cutting result must not be used as a scoring conclusion.[6]
Cutting/scoring literature in native-vessel disease is small and often non-inferiority designed; pooled conclusions cannot establish a patient-important class effect.[12]

What are possible benefits and limitations?
| Possible benefit / purpose | Limitation / required caveat |
|---|---|
| May help preparation by concentrating force along surface elements | Does not clear calcium or guarantee stent expansion |
| Option before stenting in selected de novo calcified lesions | Evidence is small, device-specific and often imaging-based |
| May aid angiographic DCB preparation in DES-ISR | No death/MI difference; not transferable to de novo calcium |
| Wedge NC was non-inferior to Scoreflex for procedure success | Short-horizon comparison between two scoring devices only |
| Balloon is removed and adds no new permanent implant | Most de novo plans still include a stent |
What are the risks?
A scoring balloon is used in coronary intervention. Risks of balloon inflation overlap with PCI generally:[3,8,15]
- Coronary dissection
- Coronary perforation
- Failure to cross, device entrapment or balloon damage
- Slow flow or no-reflow
- Acute vessel closure
- Side-branch compromise
- Myocardial infarction, stent thrombosis or arrhythmia
- Access-site bleeding and vascular complications
- Contrast-related kidney injury or allergy
- Later restenosis if a stent is used
The two acute stent thromboses in the ISAR-CALC scoring arm are not a universal rate for all scoring balloons; study complications must not be copied as a personal risk calculator.[3] Absence of in-hospital MACE in the Naviscore registry is an uncontrolled, short-horizon observation.[10]
What are the alternatives?
| Method | Core approach | Key difference from a scoring balloon |
|---|---|---|
| Standard NC balloon | Controlled mechanical expansion without scoring elements | Scoring is not “a better NC balloon” |
| Super high-pressure NC (e.g. OPN NC) | Twin-layer resistant-lesion device | ISAR-CALC is NSE Alpha-specific, not a class comparison |
| Cutting balloon | Linear modification with microblades | Not the same device; evidence is not transferable |
| Drug-coated balloon (DCB) | Antiproliferative drug transfer | Scoring does not deliver drug; it may prepare ISR |
| Rotational atherectomy | Debulks hard tissue to create a path | Different mechanism when balloons cannot cross |
| Intravascular lithotripsy (IVL) | Pressure waves that fracture calcium | Different mechanism; the balloon must still cross |
Methods may be combined; combined use is not routine for every patient.[4,5]
Preparation, discharge and recovery
Preparation depends on elective versus urgent setting, kidney function, bleeding risk, medicines, contrast history and access route. Follow hospital fasting and medicine instructions; do not stop prescribed medicines on your own.[15]
After planned uncomplicated coronary angioplasty some patients go home the same or next day. Local policy, clinical status and complications change the timing. This general frame comes from NHS patient information and is not a fixed discharge rule for every hospital in Türkiye.[15]
Discharge advice should be personalised and include access-site care, activity limits, antiplatelet and other prescriptions, follow-up, and when to seek emergency care.
Scoring-balloon use alone does not set antiplatelet duration. The plan depends on stenting, a drug-coated balloon, the clinical syndrome and bleeding–clotting risk. Stopping antiplatelets without advice can cause serious stent thrombosis.[13,15]
Bruising at the access site can occur. Increasing pain, swelling, redness, discharge or fever should prompt contact with the treating centre or another healthcare service.[15]
When should emergency services be called?
Call emergency services (112 in Türkiye) without delay for:[15]
- Chest pain that does not settle or is worsening
- Access-site bleeding that continues despite direct pressure or starts again
- Marked coldness, colour change or numbness in the treated arm or leg
- Fainting, severe breathlessness, sudden weakness or a change in consciousness
Not every bruise or mild tenderness is an emergency; uncontrolled bleeding, severe chest pain or impaired limb circulation is. Do not drive yourself with emergency symptoms. The 112 direction is a general safety frame; detailed local discharge wording should be reviewed against an official Turkish source before publication.[15]
Frequently asked questions
No. A scoring balloon does not deliver drug. It may be used to prepare DES in-stent restenosis before a drug-coated balloon; that does not mean the scoring balloon itself transfers drug.[8]
Not automatically. Imaging results are not the same as death, myocardial infarction or repeat procedures. Class-wide clinical superiority has not been shown.[6]
No. PREPARE-CALC used a mixed modified-balloon arm that also included a cutting balloon; it is not a pure scoring trial. Strategy success was lower than rotational atherectomy; it does not show clinical superiority.[7]
Assessment and decision
A scoring balloon is a temporary preparation tool used in selected coronary procedures. Planning is broader than “will a scoring balloon be used?” and includes treatment need, device crossability, calcium morphology, the stent or drug-coated balloon plan, IVUS/OCT findings and alternatives.[4,5,13,14]
The 2021 ACC/AHA/SCAI and 2024 ESC guidelines have no scoring-specific Class/LOE recommendation verified in this package; the decision rests on individual clinical assessment.[13,14]
Literature
References
Chen H, et al. Randomized study assessing the effectiveness and safety of a novel scoring balloon for percutaneous coronary intervention: the Wedge NC trial. J Thorac Dis. 2025. DOI: 10.21037/jtd-24-1457. PMID: 40400945. Trial: NCT06214247.
Sadamatsu K, et al. Comparison of pre-dilation with a non-compliant balloon versus a dual wire scoring balloon for coronary stenting. World J Cardiovasc Dis. 2013. Publisher PDF record. DOI/PMID were not verified in this package.
Rheude T, et al. Super High-Pressure Balloon versus Scoring Balloon to Prepare Severely Calcified Coronary Lesions: The ISAR-CALC Randomized Trial. EuroIntervention. 2020. DOI: 10.4244/EIJ-D-20-01000. PMID: 33258774. PMCID: PMC9724952. Trial: NCT03487432.
Riley RF, et al. SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions. JSCAI. 2024. DOI: 10.1016/j.jscai.2023.101259.
Barbato E, et al. Management strategies for heavily calcified coronary stenoses: an EAPCI clinical consensus statement in collaboration with the EURO4C-PCR group. Eur Heart J. 2023. DOI: 10.1093/eurheartj/ehad342.
Scalamogna M, et al. Modified balloons to prepare severely calcified coronary lesions before stent implantation: a systematic review and meta-analysis of randomized trials. Clin Res Cardiol. 2023. DOI: 10.1007/s00392-023-02324-y. PMID: 37778555. PMCID: PMC10684802. Registration: CRD42022360819.
Abdel-Wahab M, et al. High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions: The Randomized PREPARE-CALC Trial. Circ Cardiovasc Interv. 2018. DOI: 10.1161/CIRCINTERVENTIONS.118.007415. PMID: 30354632. Trial: NCT02502851.
Kufner S, et al. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents. JACC Cardiovasc Interv. 2017. DOI: 10.1016/j.jcin.2017.04.024. PMID: 28683939. Trial: NCT01632371.
Kandzari D, et al. Procedural effectiveness with a focused force scoring angioplasty catheter: Procedural and clinical outcomes from the Scoreflex NC trial. Cardiovasc Revasc Med. 2021. DOI: 10.1016/j.carrev.2021.03.013. PMID: 33781677. Trial: NCT03763747.
Serra Peñaranda A, et al. New scoring balloon to treat moderate-to-severe calcified coronary lesions: the first-in-man Naviscore study. REC Interv Cardiol. 2024. Institutional full-text record. DOI/PMID were not verified in this package.
Qi B, et al. Safety and effectiveness of a novel spiral-scored balloon catheter in percutaneous coronary intervention. Zhonghua Xin Xue Guan Bing Za Zhi. 2026. DOI/PMID/official URL were not verified in this package; not used for numerical clinical claims.
Sorolla Romero JA, et al. Use of cutting or scoring balloons in patients with native coronary artery disease: systematic review and meta-analysis. REC Interv Cardiol. 2024. DOI/PMID/official URL were not verified in this package.
Lawton JS, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. J Am Coll Cardiol. 2021. DOI: 10.1016/j.jacc.2021.09.006. No scoring-specific Class/LOE was verified in this package.
Vrints C, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024. DOI: 10.1093/eurheartj/ehae177. No scoring-specific Class/LOE was verified in this package.
NHS. Coronary angioplasty and stent insertion — Recovery. Official patient information. Accessed 27 August 2026.